This inventor holds 5 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Chonnam National University, Korea Atomic Energy Research Institute. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gwaangju, KR (2016)
- Gwangju, KR (2018 - 2020)
- Gyeonggi-do, KR (2022)
Company Filing History:
4 out of 196 
1 out of 428 
Years Active: 2016-2025
Title: Innovations of Jung-Joon Min in Melanoma Treatment
Introduction
Jung-Joon Min is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of medical technology, particularly in the treatment and diagnosis of melanoma. With a total of 5 patents to his name, his work focuses on developing radioactive compounds that enhance therapeutic and diagnostic capabilities.
Latest Patents
One of his latest patents is titled "Radioactive compound for treatment of melanoma and use thereof." This invention relates to a radioactive compound that exhibits improved targeting ability for melanoma, offering a pharmaceutical composition that significantly enhances treatment efficacy compared to conventional agents. The compound demonstrates excellent therapeutic effects on melanoma, making it a promising advancement in cancer treatment.
Another significant patent is "Radioactive compound for diagnosis of malignant melanoma and use thereof." This invention introduces a novel radioactive compound designed for imaging malignant melanoma, serving as a contrast agent for PET imaging. This advancement is crucial for improving diagnostic accuracy in detecting melanoma.
Career Highlights
Jung-Joon Min has worked with prestigious institutions such as Chonnam National University and the Korea Atomic Energy Research Institute. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that push the boundaries of medical science.
Collaborations
Throughout his career, Jung-Joon Min has collaborated with talented individuals, including Dong-Yeon Kim and A-Young Pyo. These partnerships have contributed to the successful development of his innovative patents.
Conclusion
Jung-Joon Min's contributions to the field of melanoma treatment and diagnosis through his innovative patents highlight his dedication to advancing medical technology. His work not only enhances therapeutic options but also improves diagnostic methods, making a significant impact in the fight against melanoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile